Skip 
Navigation Link
Health Policy & Advocacy
Resources
Basic InformationMore InformationLatest News
Primary Care Pharmacy Model Attractive to Patients1991-2014 Saw Minimal Change in Health Spending Per StateLegalized Pot May Lead to More Traffic CrashesMany Doctors Silent on Cost of Cancer CareGroup Urges Tougher Limits on Chemical in Shampoos, Cosmetics18 Percent Increase Projected in Primary Care Demand by 2023Why Patients Leave the Hospital Against Doctor's OrdersRaise the Smoking Age to 21? Most Kids Fine With ThatComprehensive Audiologic Care Feasible in Free Clinic ModelMany Tanning Salons Defy Legal Age Limits on UsersLifesaving Drugs From Pfizer in Short Supply: FDALeading U.S. Doctors' Group Takes Aim at Rising Drug PricesU.S. Hospitals Still Prescribe Too Many Antibiotics: StudyFDA Puts Brakes on Rule Requiring New 'Nutrition Facts' LabelCardiac Arrest? Someday, Drones May Come to Your RescueSAMHSA: 9.8 Million U.S. Adults Have Serious Mental IllnessFDA Asks Maker of Opioid Painkiller Opana ER to Pull Drug From MarketHealth System Sees Success With E-Visits Via Patient PortalOvercharging Common in U.S. Emergency RoomsAdvocating for a Loved OneHigh Costs for Myeloma Patients Not Getting Low-Income SubsidyGetting Bedbugs Out of Nursing Homes, Apartment Buildings - for GoodCosts of ER Treatments a Mystery to Many DocsNew Bill Intends to Repeal Limits on Physician-Owned HospitalsTechnology Can Help Patients Facing Routine DecisionsKidneys From Deceased Diabetics Might Ease Organ Shortage: StudyElements of a Patient-Centered Hospital Room IdentifiedCan Tracking Germs in One Hospital Make All Hospitals Safer?Chances of Successful CPR Dwindle as Seniors AgeNew FDA Head Outlines 'Forceful Steps' Against Opioid CrisisChecking Patient's Drug History May Help Curb Opioid AbuseAt Major Teaching Hospitals, Lower Death RatesAmericans Skeptical of Corporate-Backed Health ResearchToo Many Americans Still Go Without Cancer ScreeningsBlack, Hispanic Americans Less Likely to See a NeurologistSome Lead Poisoning Tests May Be FaultyYour Doctor's Age Might Affect Your CareMany U.S. Travelers Skip Measles Shots, Despite Infection RiskPatients Satisfied With Telehealth Primary Care VisitsNearly a Third of Drugs Hit by Safety Issues After FDA ApprovalNo Routine Screening for Thyroid Cancer: Expert PanelPAS: Internet Info Can Lower Parent Trust in Doctors' DiagnosisFDA Warns of Tattoo DangersBystander CPR Not Only Saves Lives, It Lessens Disability: StudyMore Starring Roles for Booze in Kids' Movies, Study FindsMental Health Myths Abound in the U.S.Half of U.S. Docs Get Payments From Drug, Device Industries: StudyAMA Urges Doctors to Talk About Safe Opioid Storage, DisposalRoutine Blood Tests Can Harm Patient CareApril 29 Is National Prescription Drug Take Back Day
Questions and AnswersLinksBook Reviews
Related Topics

Health Insurance
Healthcare

FDA Warns 14 Companies on Bogus Cancer 'Cures'

HealthDay News
by -- Robert Preidt
Updated: Apr 25th 2017

new article illustration

TUESDAY, April 25, 2017 (HealthDay News) -- The U.S. Food and Drug Administration on Tuesday posted warning letters to 14 companies that are selling more than 65 fake cancer treatments.

The bogus products include pills, capsules, powders, creams, teas, oils and treatment and diagnostic kits. They're most commonly marketed and sold without FDA approval on websites and social media platforms, the FDA announcement of its action said.

The treatments are frequently advertised as "natural" and often falsely labeled as dietary supplements, the agency added.

"Consumers should not use these or similar unproven products because they may be unsafe and could prevent a person from seeking an appropriate and potentially lifesaving cancer diagnosis or treatment," said Douglas Stearn. He is director of the Office of Enforcement and Import Operations in the FDA's Office of Regulatory Affairs.

"We encourage people to remain vigilant whether online or in a store, and avoid purchasing products marketed to treat cancer without any proof they will work," he said in an FDA news release.

Nicole Kornspan is a consumer safety officer at the FDA. "Anyone who suffers from cancer, or knows someone who does, understands the fear and desperation that can set in. There can be a great temptation to jump at anything that appears to offer a chance for a cure," she said in a second agency news release Tuesday.

Consumers should be wary of certain phrases often used in the marketing of these treatments: "treats all forms of cancer," "miraculously kills cancer cells and tumors," "shrinks malignant tumors," "selectively kills cancer cells," "more effective than chemotherapy," "attacks cancer cells, leaving healthy cells intact," and "cures cancer."

The FDA advises patients to always discuss cancer treatment options, including experimental drugs, with a licensed health care provider.

"There are legal ways for patients to access investigational drugs, for example, taking part in clinical trials," Kornspan said. Information can be found at the U.S. National Cancer Institute's clinical trials website.

Unproven cancer treatments for pets are also common, according to the FDA.

"Increasingly, bogus remedies claiming to cure cancer in cats and dogs are showing up online. People who cannot afford to spend large sums at the animal hospital to treat cancer in their beloved dogs and cats are searching for less expensive remedies," Kornspan said.

The FDA has issued more than 90 warning letters in the past 10 years to companies marketing hundreds of fraudulent products making cancer claims on websites, social media and in stores, the news release noted.

More information

The U.S. Federal Trade Commission has more on cancer treatment scams.